![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
100 episodes
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
Careers in Discovery Tom Froggatt
-
- Business
Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you’ll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they’d give their younger selves.
Brought to you by Singular Talent. Connect with us at:
Twitter: @singular_talent
LinkedIn: www.linkedin.com/company/singular-talent
www.singulartalent.io
-
Maude Tessier, Seismic Therapeutic
Maude Tessier is the Chief Business Officer at Seismic Therapeutic, the machine learning immunology company building a discovery platform centred on parallel drug development.
Maude joined us on Careers in Discovery to talk about the impact of machine learning on drug development, taking control of her career by literally knocking on doors, balancing humility and confidence, and much more. -
Vern de Biasi, BenevolentAI
Vern de Biasi is VP of Business Development at BenevolentAI, one of the world's leaders in the application of cutting edge technology to drug discovery.
Vern's career has seen him travel the world, from the UK to Italy, China and the US, and he shared with us the key lessons he's learned along the way. -
Jordan Lane, Ignota Labs
Jordan Lane is the Chief Scientific Officer of Ignota Labs, a company leveraging AI to rescue failed drug programmes.
Jordan joined us to talk about building conviction, seeking feedback & maintaining networks, the huge opportunity lying in failed research, and why risk is relative in your career. -
Bill Eldridge, Isogenica
Bill Eldridge is an experienced scientific and commercial leader, one of the founding team members of the VHH antibody company Isogenica, and now their CEO.
Bill joined us to talk about his career, the huge potential that still exists within antibody discovery and the magic of seeing a 96 well ELISA plate turn blue after months of failure!
Enjoy... -
Namir Hassan, Zelluna Immunotherapy
Namir Hassan is the CEO of Zelluna Immunotherapy, a cancer cell therapy company harnessing natural immunity to treat solid tumours.
Namir joined us on Careers in Discovery to talk about when precision medicine gets too precise, the importance of servant leadership and trusting the journey in your career.
Enjoy! -
Jane Dancer
Now a Non-Executive at a range of leading Biotech companies including Spirea, PharmEnable, Macomics, NanoSyrinx and Elasmogen, Jane Dancer has built a highly successful career in Business Development in the sector.
Jane joined us to discuss that career, how she created a portfolio of NED positions, the real value of an MBA and whether you really need a PhD.
Enjoy!